Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Desai

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trialJoseph H Laver, Jacqueline M Kraveka, Robert E Hutchison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2020
Fludarabine, Campath, and Low-Dose Cyclophosphamide (FCC<sup>low</sup>) with or without TBI Conditioning Results in Excellent Transplant Outcomes in Children with Severe Aplastic AnemiaRavi M Shah, Tony H Truong, Michel T Leaker, et al.
Thrombosis and Haemostasis|July 31, 2003
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA studyLesley Mitchell, Maureen Andrew, Kim Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 StudyXuexia Wang, Can-Lan Sun, Lindsey Hageman, et al.
Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2021
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiencyHenry Y Lu, Mehul Sharma, Ashish A Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology groupXuexia Wang, Wei Liu, Can-Lan Sun, et al.
Haematologica|December 28, 2023
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Anna Hecht, Julia Meyer, et al.
The Lancet. Haematology|February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 studyTanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trialJoseph H Laver, Jacqueline M Kraveka, Robert E Hutchison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2020
Fludarabine, Campath, and Low-Dose Cyclophosphamide (FCC<sup>low</sup>) with or without TBI Conditioning Results in Excellent Transplant Outcomes in Children with Severe Aplastic AnemiaRavi M Shah, Tony H Truong, Michel T Leaker, et al.
Thrombosis and Haemostasis|July 31, 2003
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA studyLesley Mitchell, Maureen Andrew, Kim Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 StudyXuexia Wang, Can-Lan Sun, Lindsey Hageman, et al.
Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2021
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiencyHenry Y Lu, Mehul Sharma, Ashish A Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology groupXuexia Wang, Wei Liu, Can-Lan Sun, et al.
Haematologica|December 28, 2023
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Anna Hecht, Julia Meyer, et al.
The Lancet. Haematology|February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 studyTanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Pageof 3